Ahmed K B Aljohani

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Advanced Non Small Cell Lung Cancer

Molecular Docking

Epidermal Growth Factor Receptor

Magnetic Resonance Imaging

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed K B Aljohani, Khaled El-Adl, Basmah Almohaywi, Omar M Alatawi, Marwa Alsulaimany, Ahmed El-Morsy, Sara A Almadani, Hussam Y Alharbi, Majed S Aljohani, Felemban Athary Abdulhaleem M, Hanan E M Osman, Samy Mohamady
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFR WT and EGFR T790M : design, synthesis, ADMET and molecular docking. RSC advances 14 (12) (2024)
Ahmed K B Aljohani, Khaled El-Adl, Basmah Almohaywi, Omar M Alatawi, Marwa Alsulaimany, Ahmed El-Morsy, Sara A Almadani, Hussam Y Alharbi, Majed S Aljohani, Felemban Athary Abdulhaleem M, Hanan E M Osman, Samy Mohamady
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFR WT and EGFR T790M : design, synthesis, ADMET and molecular docking. RSC advances 14 (12) (2024)
Marwa Alsulaimany, Khaled El-Adl, Ahmed K B Aljohani, Hussam Y Alharbi, Omar M Alatawi, Majed S Aljohani, Ahmed El-Morsy, Sara A Almadani, Abdulrahman A Alsimaree, Samir A Salama, Doaa E Keshek, Abeer A Mohamed
Design, synthesis, docking, ADMET and anticancer evaluations of N -alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors. RSC advances 13 (51) (2023)